Disclosure Panels Details Page
Hodgkin Lymphoma Panel - Disclosures as of 09/02/2016
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ranjana Advani MD | Agensys, Inc. Allos Therapeutics, Inc. Celgene Corporation Genentech, Inc. Infinity Janssen Pharmaceutica Products, LP kura Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Pharmacyclics Regeneron Pharmaceuticals, Inc. Seattle Genetics |
cellmedica Fortyseven Juno spectrum |
Bristol Myers Squibb Kyowa |
None | ✔ |
| Weiyun Ai MD, PhD | None | Seattle Genetics | None | None | - |
| Richard Ambinder MD, PhD | None | Case review 1 Chinese University Hong Kong |
None | None | ✔ |
| Patricia Aoun MD, MPH | None | None | None | None | - |
| Celeste Bello MD, MSPH | Seattle Genetics | None | Celgene Corporation Seattle Genetics |
None | - |
| Cecil Benitez MD, PhD | None | None | None | None | - |
| Karl Bernat | None | None | None | None | - |
| Philip Bierman MD | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Kristie Blum MD | Celgene Corporation Cephalon, Inc. constellation pharmaceuticals Millennium Pharmaceuticals, Inc. Morphosys Novartis Pharmaceuticals Corporation Pharmacyclics Seattle Genetics |
Morphosys | None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Robert Chen MD | Millennium Pharmaceuticals, Inc. Pharmacyclics Seattle Genetics |
Abbott Laboratories Genentech, Inc. Merck & Co., Inc. Seattle Genetics |
Genentech, Inc. Millennium Pharmaceuticals, Inc. Seattle Genetics |
None | ✔ |
| Bouthaina Dabaja MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Andres Forero-Torres MD | Abbott Laboratories Celgene Corporation Daiichi- Sankyo Co. Genentech, Inc. GSK Incyte Novartis Pharmaceuticals Corporation Oncothyreon Pfizer Inc. Pharmacyclics Seattle Genetics Synta Pharmaceuticals Corp. TRACON |
Incyte Seattle Genetics |
None | None | - |
| Leo Gordon MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Laura Hanisch PsyD | None | None | None | None | ✔ |
| Francisco Hernandez-Ilizaliturri MD | None | Celgene Corporation Novartis Pharmaceuticals Corporation Seattle Genetics |
None | None | - |
| Ephraim Hochberg MD | None | Flatiron Intervention Insights |
None | None | ✔ |
| Richard Hoppe MD | None | None | None | None | ✔ |
| Jiayi Huang MD | None | None | Viewray Inc. | None | - |
| Patrick Johnston MD, PhD | None | None | None | None | - |
| Mark Kaminski MD | None | Nordic Nanovector | None | None | ✔ |
| Nadia Khan MD | Fox Chase Cancer Center | Pharmacyclics | Genentech, Inc. | None | - |
| David Maloney MD, PhD | Celgene Corporation GSK Juno Therapeutics |
Bristol Myers Squibb ImmunoGen Seattle Genetics, Inc. |
None | None | ✔ |
| Peter Mauch MD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | ✔ |
| Monika Metzger MD | Seattle Genetics | None | None | None | - |
| Joseph Moore | ARIAD Pharmaceuticals, Inc. Genentech, Inc. Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| David Morgan MD | None | None | None | None | ✔ |
| Craig Moskowitz MD | Merck & Co., Inc. Pharmacyclics seattle genetics |
Celgene Corporation Genentech, Inc. Merck & Co., Inc. Seattle Genetics |
Seattle Genetics | None | - |
| Carolyn Mulroney MD | Amgen Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation TG therapeutics |
None | None | None | ✔ |
| Ndiya Ogba PhD | None | None | None | None | ✔ |
| Matthew Poppe MD | None | Garlington Lohn Robinson law firm Kalkstein, Johnson & Dye, PC |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Rachel Rabinovitch MD | RTOG Data Safety and Monitoring Board | None | None | None | ✔ |
| Stuart Seropian MD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Mitchell Smith MD, PhD | Infinity | Celgene Corporation | None | None | ✔ |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Jane Winter MD | GSK Medivation Seattle Genetics |
None | None | None | ✔ |
| Joachim Yahalom MD | None | None | None | None | - |